Cormorant Asset Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $42.2M | Buy |
|
|||||
|
2023
Q4 | $35.1M | Buy |
|
|||||
|
2023
Q3 | $914K | Hold |
|
|||||
|
2023
Q2 | $933K | Hold |
|
|||||
|
2023
Q1 | $722K | Hold |
|
|||||
|
2022
Q4 | $745K | Hold |
|
|||||
|
2022
Q3 | $839K | Hold |
|
|||||
|
2022
Q2 | $1.11M | Hold |
|
|||||
|
2022
Q1 | $1.64M | Hold |
|
|||||
|
2021
Q4 | $2.04M | Hold |
|
|||||
|
2021
Q3 | $2.57M | Hold |
|
|||||
|
2021
Q2 | $2.6M | Sell |
|
|||||
|
2021
Q1 | $2.42M | Hold |
|
|||||
|
2020
Q4 | $3.77M | Hold |
|
|||||
|
2020
Q3 | $4.91M | Sell |
|
|||||
|
2020
Q2 | $7.69M | Hold |
|
|||||
|
2020
Q1 | $2.88M | Hold |
|
|||||
|
2019
Q4 | $6.34M | Hold |
|
|||||
|
2019
Q3 | $5.96M | Sell |
|
|||||
|
2019
Q2 | $11.3M | Sell |
|
|||||
|
2019
Q1 | $26.8M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $40.7M | Sell |
|
|||||
|
2018
Q2 | $40.9M | Buy |
|